Related Experiment Video
Updated: May 8, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Heart failure and mechanical circulatory assist devices
Eluisa La Franca1, Rosanna Iacona, Laura Ajello
1Policlinico Universitario "Paolo Giaccone" Palermo. lajello@libero.it.
Global Journal of Health Science
|August 30, 2013
Summary
Advances in mechanical circulatory support, like left ventricular assist devices (LVADs), are transforming heart failure management. These devices offer new hope as destination therapy, not just a bridge to transplant.
Area of Science:
- Cardiology
- Medical Devices
- Biomedical Engineering
Background:
- Heart failure management has advanced significantly over the last 20 years.
- Pharmacotherapies, invasive treatments, and device-assisted therapies have improved outcomes.
- Mechanical support, including left ventricular assist devices (LVADs) and total artificial hearts, has reduced mortality in end-stage heart failure patients.
Purpose of the Study:
- To review the evolving role of Ventricular Assist Devices (VADs) in heart failure management.
- To explore VADs as a potential destination therapy, beyond their traditional "Bridge to Transplant" role.
- To describe VAD classification, indications, function, and limitations.
Main Methods:
- Literature review of VAD technology and clinical applications.
- Analysis of current trends in mechanical circulatory support for heart failure.
- Synthesis of information on VAD classification, indications, and outcomes.
Main Results:
- Left ventricular assist devices (LVADs) and total artificial hearts have improved survival for end-stage heart failure.
- Transplantation is limited by donor availability and patient comorbidities/age.
- VADs are increasingly considered as a definitive treatment (destination therapy).
Conclusions:
- Mechanical circulatory support has revolutionized heart failure care.
- VADs offer a viable alternative to transplantation for many patients.
- Future directions include refining VAD technology and expanding their use as destination therapy.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...